TP53, ETV6 and RUNX1 germline variants in a case series of patients developing secondary neoplasms after treatment for childhood acute lymphoblastic leukemia

• Stefanie V. Junk,
• Norman Klein,
• Sabine Schreek,
• Martin Zimmermann,
• Anja Möricke,
• Kirsten Bleckmann,
• Julia Alten,
• Elif Dagdan,
• Gunnar Cario,
• Christian P. Kratz,
• Martin Schrappe,
• Martin Stanulla

Affiliations

Stefanie V. Junk

Pediatric Hematology and Oncology, Hannover Medical School, Hannover

Norman Klein

Pediatric Hematology and Oncology, Hannover Medical School, Hannover

Sabine Schreek

Pediatric Hematology and Oncology, Hannover Medical School, Hannover

Martin Zimmermann

Pediatric Hematology and Oncology, Hannover Medical School, Hannover

Anja Möricke

Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel

Kirsten Bleckmann

Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel

Julia Alten

Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel

Elif Dagdan

Pediatric Hematology and Oncology, Hannover Medical School, Hannover;Department of Pathology, Ruhr-University Bochum, Bochum, Germany

Gunnar Cario

Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel

Christian P. Kratz

Pediatric Hematology and Oncology, Hannover Medical School, Hannover

Martin Schrappe

Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel

Martin Stanulla

Pediatric Hematology and Oncology, Hannover Medical School, Hannover